Pulmatrix, Inc. operates as a clinical stage biotechnology company. The Company focuses on developing therapies for the treatment of chronic respiratory diseases, including cystic fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. Pulmatrix serves patients throughout the United States.
99 Hayden Avenue
Lexington, MA 02421